SouthState Corp’s Exact Sciences EXAS Stock Holding History

SouthState Corp’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-65	Closed	-$6.6K	–	1325
2025 Q4	$6.6K	Buy	65 +10	+18%	+$803	﹤0.01%	755
2025 Q3	$3.01K	Sell	55 -136	-71%	-$6.79K	﹤0.01%	857
2025 Q2	$10.2K	Sell	191 -63	-25%	-$3.2K	﹤0.01%	781
2025 Q1	$11K	Buy	+254	New	+$12.9K	﹤0.01%	815

Other funds holding EXAS

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

PRS

Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.16B AUM 28.78% 1-Year Est. Return

PWMAG

Pinnacle Wealth Management Advisory Group Red Bank, New Jersey $1.68B AUM 31.18% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Broadwater Capital Boston, Massachusetts $138M AUM 28.86% 1-Year Est. Return

SouthState Corp's EXAS Position: Q1 2026 in Review

SouthState Corp sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 65 shares — an estimated $6.6K sold.

SouthState Corp first reported a position in EXAS in Q1 2025 and held it in 4 quarters. The position peaked at $11K in Q1 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

SouthState Corp reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
SouthState Corp sold 65 Exact Sciences shares in Q1 2026, an estimated $6.6K.
SouthState Corp first reported a position in Exact Sciences in Q1 2025 and held it in 4 quarters.
SouthState Corp's Exact Sciences position peaked at $11K in Q1 2025.
7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on SouthState Corp's 13F filing for Q1 2026, filed 5 May 2026.